Everlino Aben Ramos, PA-C | |
26012 Carolines Avenue, Andersen Afb, Yigo, GU 96929 | |
(671) 688-6123 | |
Not Available |
Full Name | Everlino Aben Ramos |
---|---|
Gender | Male |
Speciality | Physician Assistant |
Location | 26012 Carolines Avenue, Yigo, Guam |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1730557760 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363A00000X | Physician Assistant | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Everlino Aben Ramos, PA-C 26012 Carolines Avenue, Andersen Afb, Yigo, GU 96929 Ph: (671) 688-6123 | Everlino Aben Ramos, PA-C 26012 Carolines Avenue, Andersen Afb, Yigo, GU 96929 Ph: (671) 688-6123 |
News Archive
Increasing the flexibility and diagnostic capabilities in bi-plane vascular X-ray imaging, Toshiba America Medical Systems, Inc. introduces the all new Infinix™ VF-i/BP with large and mid-sized flat panel detectors. The large and mid-sized flat panel detectors provide clinicians with the ability to obtain critical variations in angle combinations while providing the necessary anatomical coverage, creating the optimal universal bi-plane vascular X-ray system for any clinical application.
Older patients with Hodgkin lymphoma (HL) and a history of heart disease face a high risk of hospitalization for cardiac complications after completing treatment, according to research published online today in Blood, the journal of the American Society of Hematology. HL is a form of cancer of arising in the lymph nodes, and approximately 8,500 people were diagnosed with the disease in 2009, according to the American Cancer Society.
University of York spinout company, Cizzle Biotechnology, has secured venture capital funding from the White Rose Technology Seedcorn Fund to continue its development of a potential new diagnostic test and treatment for lung cancer.
Massachusetts General Hospital (MGH) research has found that insulin production may persist for decades after the onset of type 1 diabetes. Beta cell functioning also appears to be preserved in some patients years after apparent loss of pancreatic function. The study results appear in the March issue of Diabetes Care.
› Verified 1 days ago